© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
July 21, 2021
The noninvasive UriFind test identifies bladder cancer based on methylation detection of exfoliated cell DNA in urine.
July 11, 2021
The federal agency has issued final guidance on how to design studies that include this patient population.
June 28, 2021
Questions remain surrounding the origin of the global pandemic.
June 18, 2021
Here are some news items in the urology field you may have missed this week.
June 17, 2021
Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.
June 01, 2021
May 27, 2021
The new treatment is a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate.
The FDA has approved the PSMA PET imaging agent 18F-DCFPyL for use in prostate cancer.
May 25, 2021
The Uro-G single-use device arrives at a time when the FDA is actively investigating reports of infections associated with reusable cystoscopes.
May 19, 2021
The device can now be marketed throughout the EU, as well as in Iceland, Liechtenstein, and Norway.